In Silico Identification of JMJD3 Demethylase Inhibitors
Overview
Medical Informatics
Authors
Affiliations
In the search for new demethylase inhibitors, we have developed a multistep protocol for in silico screening. Millions of poses generated by high-throughput docking or a 3D-pharmacophore search are first minimized by a classical force field and then filtered by semiempirical quantum mechanical calculations of the interaction energy with a selected set of functional groups in the binding site. The final ranking includes solvation effects which are evaluated in the continuum dielectric approximation (finite-difference Poisson equation). Application of the multistep protocol to JMJD3 jumonji demethylase has resulted in a dozen low-micromolar inhibitors belonging to five different chemical classes. We have solved the crystal structure of JMJD3 inhibitor 8 in the complex with UTX (a demethylase in the same subfamily as JMJD3) which validates the predicted binding mode. Compound 8 is a promising candidate for future optimization as it has a favorable ligand efficiency of 0.32 kcal/mol per nonhydrogen atom.
Emerging role of Jumonji domain-containing protein D3 in inflammatory diseases.
Li X, Chen R, Shi J, Li C, Liu Y, Gao C J Pharm Anal. 2024; 14(9):100978.
PMID: 39315124 PMC: 11417268. DOI: 10.1016/j.jpha.2024.100978.
Guay K, Ibba R, Kiappes J, Vasiljevic S, Boni F, De Benedictis M iScience. 2023; 26(10):107919.
PMID: 37822503 PMC: 10562782. DOI: 10.1016/j.isci.2023.107919.
Differential Occupancy and Regulatory Interactions of KDM6A in Bladder Cell Lines.
Ozden-Yilmaz G, Savas B, Bursali A, Eray A, Aribas A, Senturk S Cells. 2023; 12(6).
PMID: 36980177 PMC: 10047809. DOI: 10.3390/cells12060836.